Phibro Animal Health
PAHC
220 hedge funds and large institutions have $794M invested in Phibro Animal Health in 2025 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 71 increasing their positions, 79 reducing their positions, and 24 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
104% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 24
32% more call options, than puts
Call options by funds: $441K | Put options by funds: $335K
12% more funds holding
Funds holding: 196 → 220 (+24)
3.81% less ownership
Funds ownership: 100.17% → 96.36% (-3.8%)
10% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 79
19% less capital inflows, than outflows
Capital inflows: $89.9M | Capital outflows: $111M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.8M |
| 2 |
Capricorn Fund Managers
London,
United Kingdom
|
+$8.35M |
| 3 |
JP Morgan Chase
New York
|
+$7.43M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$7.23M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$4.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ExodusPoint Capital Management
New York
|
-$21.9M |
| 2 |
Brandes Investment Partners
La Jolla,
California
|
-$11.1M |
| 3 |
Millennium Management
New York
|
-$8.96M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$5.82M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.42M |
PAHC Hedge Fund Activity: Q3 2025 in Review
220 of the 7,653 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q3 2025, worth a combined $794M — up 52% from $521M a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new PAHC positions and 24 closed out — a net gain of 25 holders — while 71 added to existing stakes and 79 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $17.8M. The largest seller was ExodusPoint Capital Management, cutting an estimated $21.9M.
- 220 institutional investors held Phibro Animal Health (PAHC) as of Q3 2025, up from 196 in Q2 2025.
- Funds reported $794M of Phibro Animal Health stock for Q3 2025, up 52% quarter-over-quarter.
- 49 funds opened new Phibro Animal Health positions in Q3 2025 and 24 closed out, a net change of +25 holders.
- The largest Phibro Animal Health buyer in Q3 2025 was Fidelity Investments, an estimated $17.8M added.
- The largest Phibro Animal Health seller in Q3 2025 was ExodusPoint Capital Management, an estimated $21.9M sold.
Based on aggregated 13F filings for Q3 2025.